SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria

Yukihiro Chino, Yoshishige Samukawa, Soichi Sakai, +4

Biopharmaceutics & Drug Disposition

Electrolyte DisorderUrologyRenal DiseaseSerum Uric AcidCotransporter 2 +13

Hypercalcemia after Renal Transplantation

David S. David, Soichi Sakai, B. Lawrence Brennan, +5

New England Journal of Medicine

Electrolyte DisorderParathyroid DiseaseParathyroid GlandRenal TransplantationParathyroid Hormone +14

Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study

Yutaka Seino, Takashi Sasaki, Atsushi Fukatsu, +3

Current Medical Research and Opinion

Dermatologic evaluation of pruritus in patients on hemodialysis.

Young Aw, Sweeney Ew, David Ds, +5

PubMed

Dermatologic EvaluationHemodialysisClinical DermatologyDialysis TherapyDermatology +2

Influence of Renal Function on the 52-Week Efficacy and Safety of the Sodium Glucose Cotransporter 2 Inhibitor Luseogliflozin in Japanese Patients with Type 2 Diabetes Mellitus

Masakazu Haneda, Yutaka Seino, Nobuya Inagaki, +7

Clinical Therapeutics

Efficacy and Safety of the SGLT2 Inhibitor Luseogliflozin in Japanese Patients With Type 2 Diabetes Mellitus Stratified According to Baseline Body Mass Index: Pooled Analysis of Data From 52-Week Phase III Trials

Soichi Sakai, Kohei Kaku, Yutaka Seino, +6

Clinical Therapeutics

Efficacy and safety of luseogliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, placebo-controlled, phase II study

Yutaka Seino, Takashi Sasaki, Atsushi Fukatsu, +2

Current Medical Research and Opinion

Dose-finding study of luseogliflozin in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, double-blind, placebo-controlled, phase II study

Yutaka Seino, Takashi Sasaki, Atsushi Fukatsu, +3

Current Medical Research and Opinion

The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy

Akira Yamamoto, Mariko Harada‐Shiba, Akito Kawaguchi, +11

Atherosclerosis

Metabolic SyndromeThrombosisHomozyous Familial HypercholesterolemiaLipid DisorderCardiovascular Disease +10

Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study

Eri Muso, Masatoshi Mune, Tsutomu Hirano, +21

Clinical and Experimental Nephrology

GlomerulonephritisPolaris StudyChronic Kidney DiseasePharmacologyHyperlipidemia +5